Effects of fullerenol C60(OH)24 on cytotoxicity induced by antitumor drugs on human breast carcinoma cell lines

Materials Science Forum

Volumn 494, Issue , 2005, Pages 543-548

  Kojic V ^a   Jakimov, D ^a   Bogdanovic G ^a   Dordevic A ^b  

^a Institute of Oncology Sremska Kamenica   (Yugoslavia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Breast cancer; Cell line; Cisplatin; Cytogenetic tests; Cytotoxicity tests; Doxorubicin; Fullerenol; Genotoxicology; Taxol; Tiazofurin

Indexed keywords

ALCOHOLS; CELL GROWTH; COLORIMETRIC ANALYSIS; CYTOTOXICITY; ONCOLOGY;

CYTOGENETIC TESTS; FULLERENOL; GENOTOXICOLOGY; HUMAN BREAST CANCER CELL LINES;

DRUG THERAPY;

EID: 34248370691     PISSN: 02555476     EISSN: 16629752     Source Type: Book Series    
DOI: 10.4028/0-87849-971-7.543     Document Type: Conference Paper

References (22)

1. H.W. Kroto, J.R. Heath, S.C. O'Brien, R.F. Curl, R.E. Smaliey, C60: Buckminsterfullerene, Nature (London) 318 (1985), p. 162.
2. A. Djordjevic, Chemical derivatisation of fullerene C60 and biological investigation (Zaduzbina Andrijevic, Beograd, 2002).
3. C. Yu, J.B. Bhonsle, L.Y. Wang, J.G. Lin, B-J. Chen and L.Y. Chiang, Fullerene Science and Technology, Vol. 5 (1997), p.1407.
4. S.C. Chuech, M.K. Lai, M.S. Lee,L.Y. Chaing,T.I. Ho and S.C. Chen, Transplantation Proceedings, Vol. 31 (1999), p. 1976.
5. H-S.Lai, W.J. Chen and L.Y. Chaing, World Journal of Surgery, Vol. 24 (2000), p. 450.
6. T.-H. Ueng, H.-W. Wang and L. Y. Chaing, Fullerene Science and Technology, Vol. 7 (1999), p.681.
7. G. Bogdanović, M. Vojinović-Miloradov, V. Kojić, A. Dordević, J. Čanadi, D. Koruga, V.V. Baltić and D. Tabs, Archive of Oncology, 5/3 (1997), p. 147.
8. D. Jakimov, G. Bogdanovic, M. Baltić, S. Turšijan, L. Aleksić, A. Dordević, J. Mrdanović and M. Vojinović-Miloradov, Advances in simulation, systems theory and systems engineering, (WSEAS Press (2002), p. 117-122).
9. G. Bogdanovic, V. Kojic, A. Dordević, J. Čanadanovic- Brunet, M. Vojinović-Miloradov and V.V. Baltić, Toxicology in vitro, (2004), p. 629.
10. L.P. Zakharenko, I.K. Zakharov, E.A. Vasyunina, T.V. Karamysheva, A.M. Danilenko and A.A. Nikiforov, Russian Journal of Genetics, Vol.33/3 (1997), p. 327.
11. G. Bogdanović, J. Raletić-Savić, N. Marković, Arch. Oncol., Vol. 2 (1994), p. 181.
12. A. Djordjevic, M. Vojinovic-Miloradov, N. Petranovic, A. Devecerski, D. Lazar and B. Ribar, Fullerene Sciences and Technology, Vol. 6 (1998), p. 689.
13. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H.i Bokesch, S. Kenney and M. R.Boyd, Drug Screening.Articles, Vol. 82 (1990), p. 1107.
14. Cytogenetic analysis for radiation dose assessment - a manual (Technical reports series No. 405, International Atomic Energy Agency, Vienna, 2001).
15. Guide to short-term tests for detecting mutagenic and carcinogenic chemicals. Prepared for the International Programme on Chemical Safety (IPCS) by the International Commission for Protection Against Mutagens and Carcinogens, World Health Organisation, Geneva, 1985.
16. J.M. Barch, The ACT cytogenetic laboratory manual - 2nd edition (Raven Press, New York, 1991).
17. R.S. Verma, A. Babu, Human chromosomes: Principles and techniques - 2nd edition. (McGraw-Hill, Health professions division, New York, 1995).
18. M Fenech, Drug Discovery Today, Vol. 7 No. 22 (2002), p 1128.
19. T.V. De Vita, J.R.S. Hellman and A.S. Rosenberg, Cancer principles and practice of oncology (Philadelphia: Lippincott-Raven, 1997: 1-16, 375-512).
20. G. Weber and N. Preida, Adv. Enzime Regul., Vol. 34 (1994), p. 71.
21. Q. Li, Y. Xiu, X. Zhang, R. Liu, Q. Du, X. Shun, S. Chen and W. Li, Nuclear Medicine and Biology, Vol. 29 (2002), p. 707.
22. C.M. Sayes, J.D. Fortner, W. Guo, D. Lyon, A.D. Boyd, K.D. Ausman, Y.J. Tao, B. Sitharaman, L.J. Wilson, J.B. Hughes, J.L. West and V.L. Colvin, Nano Letters Vol.0 (2004), P. A-G.